Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 7/2021

26-02-2021

Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays

Auteurs: Ozgen Ahmet Yildirim, Kerem Poyraz, Erkan Erdur

Gepubliceerd in: Quality of Life Research | Uitgave 7/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Pandemics can be associated with anxiety and depression in cancer patients who are undergoing treatment. In the present study, we aimed to perform a comparative evaluation of the conditions of cancer patients before and during the severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) pandemic using the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) to detect the impact of the pandemic on treatment delays that are associated with anxiety and depression in cancer patients. In addition, the effect of public transport use on treatment delays was examined.

Methods

BDI and BAI were administered to 595 breast, ovarian, colon and gastric cancer patients before and during the pandemic. The questionnaires were administered by the physician blindly, who was unaware of the delay of the patients. The number of days by which the patients delayed their treatment due to the fear of contamination were recorded retrospectively. Correlation analyses were performed between the obtained scores and treatment delays.

Results

The depression and anxiety levels in cancer patients were found to increase during the pandemic (p = 0.000), and this increase was positively correlated with the disruption of their treatment (p = 0.000, r = 0.81). Depression and anxiety levels and treatment delays were higher in elderly patients (p = 0.021). Depression and anxiety were more pronounced in female patients (p = 0.000). Moreover, treatment delays were more common in patients who had to use public transportation (p = 0.038).

Conclusion

SARS-CoV-2 pandemic may increase anxiety and depression in cancer patients. This can cause patients to experience treatment delays due to concerns about becoming infected. At this point, if necessary, assistance should be obtained from psychiatric and public health experts.
vorige artikel Comparison of the anxiety, depression and their relationship to quality of life among adult acute leukemia patients and their family caregivers: a cross-sectional study in China
volgende artikel The association between social isolation and musculoskeletal health in older community-dwelling adults: findings from the Hertfordshire Cohort Study
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., & Hu, Y. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan. Lancet, 395(10223), 497–506.PubMedPubMedCentral
2.
Hui, D. S., Azhar, I., Madani, E., Ntoumi, T. A., Kock, F., & Dar, R. O. (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International Journal of Infectious Diseases, 91, 264–266.PubMedPubMedCentral
3.
Lu, H., Stratton, C. W., & Tang, Y. W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan China: The mystery and the miracle. Journal of Medical Virology, 92(4), 401–402.PubMedPubMedCentral
4.
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020). Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England Journal of Medicine, 382(13), 1199–1207.PubMed
5.
Demirbilek, Y., Pehlivantürk, G., Özgüler, Z. Ö., & Alp Meşe, E. (2020). COVID-19 outbreak control, example of ministry of health of Turkey. Turkish Journal of Medical Sciences, 50, 489–494.PubMedPubMedCentral
6.
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011). Cancer immunoediting: Integrating immunity’s roles in cancer suppression and promotion. Science (New York, NY), 331(6024), 1565–1570.
7.
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2015). Immunological effects of conventional chemotherapy and targeted anticancer agents. Cancer Cell, 28(6), 690–714.PubMed
8.
Edwards, B. K., Noone, A. M., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., et al. (2014). Annual Report to the Nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer, 120(9), 1290–1314.PubMed
9.
Aldashek, J. J., Hajjar, J., Chemaly, R. F., & Razelle, K. (2020). Are cancer patients at higher risk of death with COVID-19? Journal of Immunotherapy Precision Oncology, 3(2), 49–51.
10.
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., et al. (2020). Cancer patients in SARSCoV-2 infection: A nationwide analysis in China. Lancet Oncology, 21, 335–337.PubMed
11.
Wang, C., Horby, P. W., Hayden, F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global health concern. Lancet, 395(10223), 470–473.PubMedPubMedCentral
12.
Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., et al. (2020). Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 outbreak. Cancer Discovery, 10(6), 783–791.PubMedPubMedCentral
13.
Yang, K., Sheng, Y., Huang, C., Jin, Y., Xiong, N., Jiang, K., et al. (2020). Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: A multicentre, retrospective, cohort study. Lancet Oncology, 21(7), 904–913.PubMed
14.
Martín-Moro, F., Marquet, J., Piris, M., Michael, B. M., Saez, A. J., Corona, M., et al. (2020). Survival study of hospitalised patients with concurrent COVID-19 and haematological malignancies. British Journal of Haematology, 190(1), 16–20.
15.
Ma, J., Yin, J., Qian, Y., & Wu, Y. (2020). Clinical characteristics and prognosis in cancer patients with COVID-19: A single center’s retrospective study. The Journal of Infection, 81(2), 318–356.PubMedPubMedCentral
16.
Cook, G., John Ashcroft, A., Pratt, G., Popat, R., Ramasamy, K., Kaiser, M., et al. (2020). Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. British Journal of Haematology, 190(2), 83–86.
17.
Miyashita, H., Mikami, T., Chopra, N., Yamada, T., Chernyavsky, S., Rizk, D., et al. (2020). Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Annals of Oncology, 31(8), 1088–1089.PubMed
18.
Petrilli, C. M., Jones, S. A., Yang, J., Rajagopalan, H., O’Donnel, L., Chernyak, Y., et al. (2020). Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study. BMJ, 369, 1966.
19.
De Lusignan, S., Dorward, J., Correa, A., Jones, N., Akinyemi, O., Amirthalingam, G., et al. (2020). Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: A cross-sectional study. Lancet Infectious Diseases, 20(9), 1034–1042.PubMed
20.
Palaiodimos, L., Kokkinidis, D. G., Li, W., Karamanis, D., Ognibene, J., Arora, S., et al. (2020). Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism: Clinical and Experimental, 108(15), 42–62.
21.
Cecconi, M., Piovani, D., Brunetta, E., Aghemo, A., Greco, M., Ciccarelli, M., et al. (2020). Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for covid-19 infection in Lombardy, Italy. Journal of Clinical Medicine, 9(5), 1548.PubMedCentral
22.
Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., et al. (2020). Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. The Journal of Infection, 80(6), 639–645.PubMedPubMedCentral
23.
Liu, Y., Du, X., Chen, J., Jin, Y., Peng, L., Wang, H. H. X., et al. (2020). Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. The Journal of Infection, 81(1), 6–12.
24.
Satin, J. R., Linden, W., & Phillips, M. J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer, 115, 5349–5361.PubMed
25.
Sullivan, D. R., Forsberg, C. W., Ganzini, L., Au, D. H., Gould, M. K., Provenzale, D., et al. (2016). Longitudinal changes in depression symptoms and survival among patients with lung cancer: A national cohort assessment. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(33), 3984–3991.
26.
Osazuwa-Peters, N., Arnold, L. D., Loux, T. M., Varvares, M. A., & Schootman, M. (2018). Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis. Oral Oncology, 81, 29–34.PubMed
27.
Özdin, S., & Bayrak Özdin, Ş. (2020). Levels and predictors of anxiety, depression and health anxiety during COVID-19 pandemic in Turkish society: The importance of gender. International Journal of Social Psychiatry, 66(5), 504–511.PubMed
28.
Fauci, A. S., Lane, C., & Redfield, R. R. (2020). Covid-19 navigating the uncharted. New England Journal of Medicine, 382(13), 1268–1269.PubMed
29.
Molica, M., Mazzone, C., Cordone, I., Pasquale, A., Niscola, P., & de Fabritiis, P. (2020). SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies. British Journal of Haematology, 190(1), 5–8.
30.
Karacin, C., Bilgetekin, I., Basal, B., F., & Oksuzoglu, O.B. (2020). How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer. Future Oncology (London, England), 16(29), 2283–2293.
31.
Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Annals of General Psychiatry, 4, 561–571.
32.
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clinical Psychology Review, 8(1), 77–100.
33.
Tegin, B. (1987). Cognitive disorders in depression: A review according to Beck Model. Ankara. Psychology Journal, 6, 116–123.
34.
Hisli, N. (1988). A study on the validity of the Beck Depression Inventory. Psychology Journal, 22, 118–126.
35.
Beck, A. T., Ebstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56(6), 893–897.PubMed
36.
Ulusoy, M., Sahin, N. H., & Erkmen, H. (1998). The Beck anxiety inventory: Psychometric properties. Journal of Cognitive Psychotherapy, 12(2), 163–172.
37.
38.
Généreux, M., Schluter, P. J., Hung, K. K., Wong, C. S., Mok, C. P. Y., O’Sullivan, T., et al. (2020). One virus, four continents, eight Countries: An interdisciplinary and international study on the psychosocial impacts of the COVID-19 pandemic among adults. International Journal of Environmental Research and Public Health, 17(22), 8390.PubMedCentral
39.
40.
Ozamiz-Etxebarria, N., Dosil-Santamaria, M., Picaza-Gorrochategui, M., & Idoiaga-Mondragon, N. (2020). Stress, anxiety, and depression levels in the initial stage of the COVID-19 outbreak in a population sample in the northern Spain. Cadernos de Saude Publica, 36(4), e00054020.PubMed
41.
Wang, C., Pan, R., Wan, X., Tan, Y., Xu, L., McIntyre, R. S., et al. (2020). A longitudinal study on the mental health of general population during the COVID-19 epidemic in China. Brain, Behavior, and Immunity, 87, 40–48.PubMedPubMedCentral
42.
43.
De Las Heras, B., Saini, K. S., Boyle, F., Ades, F., De Azabuja, E., Bozovic-Spasojevic, I., et al. (2020). Cancer treatment and research during the COVID-19 pandemic: Experience of the first 6 months. Oncology and Therapy, 4, 1–12.
44.
Cai, Y., Xu, Y., Xu, D., Wang, Y., Wang, X., Sun, C., et al. (2020). Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus. Medical Oncology (Northwood, London, England), 37(9), 78.
45.
Colombo, I., Zaccarelli, E., Del Grande, M., Tomao, F., Multinu, F., Betella, I., et al. (2020). ESMO management and treatment adapted recommendations in the COVID-19 era: Gynaecological malignancies. ESMO Open, 5(Suppl 3), e000827.PubMedPubMedCentral
46.
Moccia, L., Janiri, D., Pepe, M., Dattoli, L., Molinaro, M., De Martin, V., et al. (2020). Affective temperament, attachment style, and the psychological impact of the COVID-19 outbreak: An early report on the Italian general population. Brain, Behavior, and Immunity, 87, 75–79.PubMedPubMedCentral
47.
Vindegaard, N., & Benros, M. E. (2020). COVID-19 pandemic and mental health consequences: Systematic review of the current. Brain, Behavior, and Immunity, 89, 531–542.PubMedPubMedCentral
48.
Thapa, S. B., Mainali, A., Schwank, S. E., & Acharya, G. (2020). Maternal mental health in the time of the COVID-19 pandemic. Acta Obstetricia et Gynecologica Scandinavica, 99(7), 817–818.PubMed
49.
Hongyu, Z., Xiaoyi, H., Guanhua, F., Liping, L., Qingjun, Hu., Qinming, Q., et al. (2020). COVID-19 infection outbreak increases anxiety level of general public in China: Involved mechanisms and influencing factors. Journal of Affective Disorders, 276, 446–452.
50.
51.
52.
Shinan-Altman, S., Levkovich, I., & Tavori, G. (2020). Healthcare utilization among breast cancer patients during the COVID-19 outbreak. Palliative Supportive Care, 29, 1–7.
53.
Al-Shamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., et al. (2020). A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: An international collaborative group. The Oncologist, 25(6), 936–945.
54.
Cortiula, F., Pettke, A., Bartoletti, M., Puglisi, F., & Helleday, T. (2020). Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 31(5), 553–555.
Metagegevens
Titel
Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays
Auteurs
Ozgen Ahmet Yildirim
Kerem Poyraz
Erkan Erdur
Publicatiedatum
26-02-2021
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-021-02795-4

Andere artikelen Uitgave 7/2021

Quality of Life Research 7/2021 Naar de uitgave

OriginalPaper

What’s important when caring for a loved one? Population-based preference weights for the Adult Social Care Outcomes Toolkit for informal carers (ASCOT-Carer) for Austria

OriginalPaper

Moving beyond family: unequal burden across mental health patients’ social networks

OriginalPaper

Willingness to pay for a quality-adjusted life year for depressive disorders compared to heart disease based on population preferences

OriginalPaper

The role of response domain and scale label in the quantitative interpretation of patient-reported outcome measure response options

OriginalPaper

Agreement between proxy- and self-report scores on PROMIS health-related quality of life domains in pediatric burn survivors: a National Institute on Disability, Independent Living, and Rehabilitation Research Burn Model System Study

OriginalPaper

The association between diabetic complications and health-related quality of life in patients with type 2 diabetes: a cross-sectional study from Iran